Jean-Yves Scoazec Selected Research

Neuroendocrine Carcinoma

1/2021	Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
1/2021	Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network.
6/2019	Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
2/2018	Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study.
1/2017	Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
1/2013	Antitumor effect of everolimus in preclinical models of high-grade gastroenteropancreatic neuroendocrine carcinomas.
12/2012	Intervention in gastro-enteropancreatic neuroendocrine tumours.
10/2009	Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases.
8/2009	Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Yves Scoazec Research Topics

Disease

117	Neoplasms (Cancer) 12/2022 - 02/2002
18	Neoplasm Metastasis (Metastasis) 04/2021 - 08/2002
16	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2002
16	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2019 - 06/2009
12	Carcinogenesis 01/2022 - 09/2004
11	Fibrosis (Cirrhosis) 01/2022 - 04/2002
10	Infections 01/2015 - 05/2002
10	Carcinoma (Carcinomatosis) 04/2014 - 10/2003
10	Adenocarcinoma 02/2010 - 09/2002
9	Neuroendocrine Carcinoma 01/2021 - 08/2009
9	Adenoma (Adenomas) 04/2014 - 08/2003
8	Hepatitis 09/2017 - 03/2002
7	Melanoma (Melanoma, Malignant) 06/2022 - 01/2015
7	Colonic Neoplasms (Colon Cancer) 04/2021 - 11/2007
7	Hepatitis C 08/2014 - 09/2003
6	Colorectal Neoplasms (Colorectal Cancer) 12/2011 - 04/2003
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2016
5	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2016
5	Hypoxia (Hypoxemia) 01/2018 - 05/2002
4	Liver Diseases (Liver Disease) 01/2022 - 07/2007
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 01/2017
4	Carcinoid Tumor (Carcinoid) 01/2021 - 01/2011
4	Hyperplasia 04/2020 - 02/2003
4	Disease Progression 01/2020 - 10/2003
4	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2017 - 03/2006
4	Inflammation (Inflammations) 10/2009 - 09/2006
3	Hypertension (High Blood Pressure) 01/2019 - 10/2009
3	Primitive Neuroectodermal Tumors (PNET) 01/2018 - 10/2015
3	Liver Neoplasms (Liver Cancer) 05/2017 - 07/2004
3	Hemorrhage 01/2017 - 02/2006
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2016 - 05/2007
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 08/2015 - 05/2007
3	Non-alcoholic Fatty Liver Disease 09/2014 - 03/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2012 - 07/2009
2	Neuroblastoma 12/2022 - 11/2005
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2021
2	Lymphoma (Lymphomas) 01/2022 - 08/2003
2	Wounds and Injuries (Trauma) 01/2022 - 05/2002
2	Breast Neoplasms (Breast Cancer) 04/2021 - 03/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 02/2014
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 04/2020 - 02/2006

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 04/2022 - 03/2004
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
9	LigandsIBA 01/2016 - 08/2002
9	Netrin-1IBA 08/2012 - 04/2003
7	Immune Checkpoint InhibitorsIBA 06/2022 - 10/2017
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 10/2003
6	Biological ProductsIBA 06/2022 - 05/2010
6	Pharmaceutical PreparationsIBA 01/2022 - 10/2009
6	Chromogranin AIBA 01/2021 - 12/2005
6	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 08/2003
6	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2006
5	PlatinumIBA 01/2022 - 01/2017
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2021 - 01/2009
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 08/2009
5	Messenger RNA (mRNA)IBA 01/2020 - 07/2007
5	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 10/2004
5	SynaptophysinIBA 01/2017 - 02/2003
4	CateninsIBA 01/2022 - 04/2012
4	Temozolomide (Temodar)FDA LinkGeneric 06/2019 - 06/2012
4	Cetuximab (Erbitux)FDA Link 01/2019 - 01/2016
4	MTOR InhibitorsIBA 01/2018 - 01/2010
4	Everolimus FDA Link 01/2018 - 06/2008
4	Dihydrotachysterol (AT 10)IBA 01/2018 - 02/2007
4	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2017 - 06/2006
4	Gemcitabine FDA Link 10/2015 - 08/2006
4	LipidsIBA 09/2015 - 12/2012
4	IntegrinsIBA 01/2015 - 08/2002
4	Antiviral Agents (Antivirals)IBA 08/2014 - 04/2004
3	Transcription Factors (Transcription Factor)IBA 12/2022 - 02/2012
3	Anaplastic Lymphoma KinaseIBA 01/2022 - 12/2016
3	B7-H1 AntigenIBA 01/2022 - 01/2016
3	InterferonsIBA 01/2022 - 05/2004
3	AntibodiesIBA 01/2022 - 02/2014
3	Hormones (Hormone)IBA 04/2021 - 12/2005
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2018
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 12/2019
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2008
3	Streptozocin (Streptozotocin)FDA Link 01/2018 - 08/2009
3	Hepatocyte Nuclear FactorsIBA 05/2017 - 03/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011 - 12/2006
3	AflatoxinsIBA 04/2011 - 06/2004
3	Octreotide (Sandostatin)FDA LinkGeneric 01/2011 - 01/2009
3	EnzymesIBA 01/2010 - 12/2006
3	Fluorouracil (Carac)FDA LinkGeneric 08/2009 - 08/2006
3	beta CateninIBA 03/2006 - 09/2003
3	Ribavirin (Virazole)FDA LinkGeneric 05/2004 - 08/2002
2	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2016
2	Immunologic Factors (Immunomodulators)IBA 11/2021 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 12/2014
2	trans-sodium crocetinate (crocetin)IBA 04/2020 - 10/2014

Therapy/Procedure

32	Therapeutics 12/2022 - 10/2003
27	Liver Transplantation 01/2022 - 04/2002
21	Drug Therapy (Chemotherapy) 01/2022 - 03/2003
8	Radiotherapy 01/2021 - 08/2006
7	Immunotherapy 01/2022 - 06/2016
4	Precision Medicine 01/2022 - 12/2017
3	Chemoradiotherapy 01/2018 - 01/2016
3	Pancreatectomy 02/2010 - 08/2003
2	Colectomy 04/2021 - 01/2019